2q-, a non-random chromosomal abnormality in human non-small-cell lung cancer

被引:8
|
作者
Lu, YJ
Dong, XY
Guo, SP
Zhang, RG
Ke, Y
Zhang, LZ
Xu, LH
Cheng, SJ
机构
[1] CHINESE ACAD MED SCI,CANC INST HOSP,DEPT ETIOL & CHEM CARCINOGENESIS,BEIJING 100021,PEOPLES R CHINA
[2] CHINESE ACAD MED SCI,CANC INST HOSP,DEPT THORAC SURG,BEIJING 100021,PEOPLES R CHINA
[3] PUMC,BEIJING 100021,PEOPLES R CHINA
[4] BEIJING INST CANC RES,DEPT CELL BIOL,BEIJING 100034,PEOPLES R CHINA
关键词
D O I
10.1093/carcin/17.8.1589
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many cytogenetic studies have been carried out on human lung cancer, However the chromosomal alterations in human lung cancers are often complex, making it difficult to identify some abnormal chromosomes by routine cytogenetic studies, Using FISH (fluorescence in situ hybridization), we studied the alterations of chromosome 2, 3, and 17 in four human bronchial epithelial cell lines, two human non-small-cell lung cancer (NSCLC) cell lines, and 12 primary NSCLC specimens, 2q- was found in three out of four human bronchial epithelial cell lines, two NSCLC cell lines, and three out of seven primary NSCLC specimens tested. 3p- was noted in five cases of twelve primary NSCLC patients examined, 3p- was the first cytogenetic discovery and the most prominent abnormality in lung cancer, 2q- has rarely been reported in human lung cancer but loss of heterozygosity by RFLP analysis for 2q had been reported in human NSCLC, Our results indicate that 2q- was also a non-random chromosomal abnormality in the early stage of the development of human NSCLC, There would be one or more putative tumor suppressor gene(s) on the long arm of chromosome 2, Loss of the gene(s) presumably contributes to the carcinogenesis of human non-small-cell lung cancer.
引用
收藏
页码:1589 / 1593
页数:5
相关论文
共 50 条
  • [1] Non-Small-Cell Lung Cancer
    不详
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2008, 28 (20): : 61 - 61
  • [2] Non-small-cell lung cancer
    Cesare Gridelli
    Antonio Rossi
    David P. Carbone
    Juliana Guarize
    Niki Karachaliou
    Tony Mok
    Francesco Petrella
    Lorenzo Spaggiari
    Rafael Rosell
    Nature Reviews Disease Primers, 1
  • [3] Non-small-cell lung cancer
    Gridelli, Cesare
    Rossi, Antonio
    Carbone, David P.
    Guarize, Juliana
    Karachaliou, Niki
    Mok, Tony
    Petrella, Francesco
    Spaggiari, Lorenzo
    Rosell, Rafael
    NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [4] Non-small-cell lung cancer
    不详
    NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01):
  • [6] Non-small-cell lung cancer
    Goldstraw, Peter
    Ball, David
    Jett, James R.
    Le Chevalier, Thierry
    Lim, Eric
    Nicholson, Andrew G.
    Shepherd, Frances A.
    LANCET, 2011, 378 (9804): : 1727 - 1740
  • [7] Advanced Non-Small-Cell Lung Cancer
    Kwon, Hyun W.
    Ham, Soo-Youn
    Shin, Sang W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1997 - +
  • [8] Pembrolizumab in Non-Small-Cell Lung Cancer
    Sorscher, Steven
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (10): : 996 - 997
  • [9] Encephalitis in non-small-cell lung cancer
    Costa e Silva, M.
    Silva, E.
    Mendes, A.
    Barroso, A.
    PULMONOLOGY, 2021, 27 (06): : 582 - 583
  • [10] Immunotherapy of non-small-cell lung cancer
    Reinmuth, Niels
    Merk, Martina
    Duell, Thomas
    ONKOLOGE, 2021, 27 (02): : 179 - 190